Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Pediatric Hematology/Oncology
•
Neurology
•
Child Neurology
•
Neurogenetics
At what point should surgical intervention be considered for vestibular schwannomas or other tumors in pediatric NF2 patients?
Related Questions
What workup do you consider for a developmentally typical child with multiple large café au lait macules but no other signs of neurofibromatosis?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?
When do you consider testing with stroke gene panels in young stroke patients?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?
Is there utility to ordering biochemical screening labs for global developmental delay?
How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?
